SFX by Ex Libris Inc.

Title:	Activation of Raf-1 by 14-3-3 proteins
Source:	Nature [0028-0836] Fantl, Wendy yr:1994

Basic

Full text

Full text available via Nature

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Jin, K T Y. "Function of 14-3-3 proteins." Nature 382.6589 (1996): 308-308.
description	2.	Hu CJ, Iyer S, Sataur A, Covello KL, Chodosh LA, S, C. "Differential Regulation of the Transcriptional Activities of Hypoxia-Inducible Factor 1 Alpha (HIF-1{alpha}) and HIF-2{alpha} in Stem Cells." Molecular and cellular biology 26.9: 3514-26.
description	3.	Hu, C. "Differential Roles of Hypoxia-Inducible Factor 1 alpha (HIF-1 alpha ) and HIF-2 alpha in Hypoxic Gene Regulation." Molecular and cellular biology 23.24 (2003): 9361-9374.
description	4.	Kim, Dae I. "An improved smaller biotin ligase for BioID proximity labeling." Molecular biology of the cell 27.8 (2016): 1188-1196.
description	5.	Yan, Huan u. "RKIP and 14-3-3Îµ exert an opposite effect on human gastric cancer cells SGC7901 by regulating the ERK/MAPK pathway differently." Digestive diseases and sciences 58.2 (2013): 389-396.
description	6.	Baxter, H C. "Specific 14-3-3 isoform detection and immunolocalization in prion." Biochemical society transactions 30.4 (2002): 387-.
description	7.	Avruch, J. "A dimeric 14-3-3 protein is an essential cofactor for Raf kinase activity." Nature 394.6688 (1998): 88-92.
description	8.	Freitas, A A A. "Population biology of lymphocytes: the flight for survival." Annual review of immunology 18.1 (2000): 83-111.
description	9.	Carreño, Flávia R R. "14-3-3 epsilon modulates the stimulated secretion of endopeptidase 24.15." Journal of neurochemistry 93.1 (2005): 10-25.
description	10.	Yeo EJ, Jong-Wan W. "YC-1: a potential anticancer drug targeting hypoxia-inducible factor 1." Journal of the National Cancer Institute 95.7 (2003): 516-25.
description	11.	Pawson, T. "Signaling Through Scaffold, Anchoring, and Adaptor Proteins." Science 278.5346 (1997): 2075-80.
description	12.	Hu, X. "Transplantation of hypoxia-preconditioned mesenchymal stem cells improves infarcted heart function via enhanced survival of implanted cells and angiogenesis." Journal of thoracic and cardiovascular surgery 135.4 (2008): 799-808.
description	13.	Loor, G., G. "Role of hypoxia-inducible factor in cell survival during myocardial ischemia–reperfusion." Cell death and differentiation 15.4 (2008): 686-690.
description	14.	Goldrath, A W W. "Selecting and maintaining a diverse T-cell repertoire." Nature 402.6759 (1999): 255-262.
description	15.	Houtman, JCD D. "Examining multiprotein signaling complexes from all angles - The use of complementary techniques to characterize complex formation at the adapter protein, linker for activation of T cells." The FEBS journal 272.21 (2005): 5426-5435.
description	16.	GORDAN, John D. "HIF and c-Myc: sibling rivals for control of cancer cell metabolism and proliferation." Cancer cell 12.2 (2007): 108-13.
description	17.	Jazwa, A. "New Vectors and Strategies for Cardiovascular Gene Therapy." Current gene therapy 7.1 (2007): 7-23.
description	18.	Simon, M Celeste C. "HIF-2alpha Promotes Hypoxic Cell Proliferation by Enhancing c-Myc Transcriptional Activity." Cancer cell 11.4 (2007): 335-47.
description	19.	Raval, Raju R R. "Contrasting properties of hypoxia-inducible factor 1 (HIF-1) and HIF-2 in von Hippel-Lindau-associated renal cell carcinoma." Molecular and cellular biology 25.13 (2005): 5675-86.
description	20.	Ashcroft, Veronica A A. "Role of hypoxia-inducible factor (HIF)-1alpha versus HIF-2alpha in the regulation of HIF target genes in response to hypoxia, insulin-like growth factor-I, or loss of von Hippel-Lindau function: implications for targeting the HIF pathway." Cancer research 66.12 (2006): 6264-70.